Literature DB >> 15541097

Angiolymphoid hyperplasia with eosinophilia treated with anti-interleukin-5 antibody (mepolizumab).

M Braun-Falco, S Fischer, S-G Plötz, J Ring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15541097     DOI： 10.1111/j.1365-2133.2004.06239.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

1.  Mepolizumab.

Authors:  Dennis J Cada; Ross J Bindler; Danial E Baker
Journal:  Hosp Pharm       Date:  2016-05

2.  Angiolymphoid hyperplasia with eosinophilia of root of nose: a rare phenomenon.

Authors:  M Panduranga Kamath; Kiran M Bhojwani; Ajay M Bhandarkar; Radha R Pai; Natashya H Rent
Journal:  J Clin Diagn Res       Date:  2014-03-15

Review 3.  Clinical overview of cutaneous features in hypereosinophilic syndrome.

Authors:  Sabine Gisela Plötz; Bettina Hüttig; Birgit Aigner; Christian Merkel; Knut Brockow; Cezmi Akdis; Ulf Darsow; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

4.  Angiolymphoid Hyperplasia with Eosinophilia Involving the Occipital Artery: Case Report and Review of Literature.

Authors:  Laia Fite-Trepat; Miriam Martos-Fernandez; Margarita Alberola-Ferranti; Alba De Pablo-Garcia-Cuenca; Coro Bescosatin
Journal:  J Clin Diagn Res       Date:  2017-03-01

5.  A Long-Term Follow-Up of Angiolymphoid Hyperplasia with Eosinophilia Treated by Corticosteroids: When a Traditional Therapy is Still Up-to-Date.

Authors:  Serena Lembo; Anna Balato; Teresa Cirillo; Nicola Balato
Journal:  Case Rep Dermatol       Date:  2011-03-05

6.  Angiolymphoid hyperplasia with eosinophilia: efficacy of isotretinoin?

Authors:  Fouad El Sayed; Rola Dhaybi; Alfred Ammoury; Myrna Chababi
Journal:  Head Face Med       Date:  2006-10-04       Impact factor: 2.151

7.  Angiolymphoid Hyperplasia with Oeosinophilia Showing Promising Result with Intralesional Radio-frequency Ablation Therapy: A New Cost-effective and Hassle-free Modality of Treatment.

Authors:  Chintaginjala Aruna; Senthil Kumar Alagappan; Ramamurthy Damaraju Venkata Satya Bhaskara; Sruthi Kondaveeti
Journal:  J Cutan Aesthet Surg       Date:  2016 Oct-Dec

Review 8.  Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma.

Authors:  Florence Roufosse
Journal:  Front Med (Lausanne)       Date:  2018-04-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.